Medexus Pharmaceuticals Inc.

Toronto Stock Exchange:MDP.TO

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Drugstores & Retail Pharmacies

💊 Pharmaceuticals

Location

Canada

Market Cap

USD 65.82 M

Share Price

USD 2.04

Avg Daily Volume

38,563

Change (1 day)

-4.82%

Change (1 year)

19.38%

Change (YTD)

-15.14%

Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2025: USD 36.15 M

Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) is USD 36.15 M for the year ending March 31, 2025, a -5.95% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.

Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2024 was USD 38.44 M, a -20.34% change year over year.
Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2023 was USD 48.25 M, a -12.35% change year over year.
Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2022 was USD 55.05 M, a 52.19% change year over year.
Medexus Pharmaceuticals Inc. Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2021 was USD 36.17 M, a 75.94% change year over year.